KORU Medical Systems (KRMD) Change in Receivables (2010 - 2026)
KORU Medical Systems' (KRMD) quarterly Change in Receivables came in at -$717115.0 in Q2 2026, up 30.63% year-over-year from -$548955.2 in Q2 2025, and down 215.33% quarter-over-quarter from -$227414.0 in Q1 2026.
Powered by 
Analysis
KORU Medical Systems (KRMD) Change in Receivables (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has reported Change in Receivables for 12 consecutive years, with -$717115.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables rose 30.63% year-over-year to -$717115.0 in Q2 2026; TTM through Jun 2026 was $349803.0, a 137.59% increase from a year earlier, with the FY2025 full-year figure at $489199.0, down 70.8% from the prior year.
- Change in Receivables was -$717115.0 for Q2 2026 at KORU Medical Systems, down from -$227414.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.2 million in Q2 2024 and troughed at -$1.5 million in Q4 2022.
- A 5-year average of $92918.6 and a median of $191006.5 in 2023 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 392.3% in 2024, down 829.65% in 2024.
- Over 5 years, Change in Receivables stood at -$1.5 million in 2022, then jumped by 110.37% to $153352.0 in 2023, then surged by 262.6% to $556050.0 in 2024, then surged by 43.5% to $797948.0 in 2025, then sank by 189.87% to -$717115.0 in 2026.
- The last three Change in Receivables figures came in at -$717115.0 (Q2 2026), -$227414.0 (Q1 2026), and $797948.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -90.00 Mn |
| 10 | KORU Medical Systems | 144.70 Mn | 136.40 Mn | 7.85 Mn | -717,115.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -717,115.00 |
| Mar 31, 2026 | -227,414.00 |
| Dec 31, 2025 | 797,948.00 |
| Sep 30, 2025 | 496,384.00 |
| Jun 30, 2025 | -1.03 Mn |
| Mar 31, 2025 | 228,661.00 |
| Dec 31, 2024 | 556,050.00 |
| Sep 30, 2024 | -681,381.00 |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 607,125.00 |
| Dec 31, 2023 | 153,352.00 |
| Sep 30, 2023 | 93,385.00 |
| Jun 30, 2023 | -408,404.00 |
| Mar 31, 2023 | 647,994.00 |
| Dec 31, 2022 | -1.48 Mn |
| Sep 30, 2022 | 990,627.00 |
| Jun 30, 2022 | 901,941.00 |
| Mar 31, 2022 | -447,489.00 |
| Dec 31, 2021 | 470,221.00 |
| Sep 30, 2021 | 545,265.00 |